Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

Friday, December 2 2022 | 15 h 32 min | New Products, News, Press Release, TechNews

Bausch + Lomb announced the Canadian launch of Biotrue Advanced Multi-Purpose Solution The new contact lens solution, which was launched as Biotrue...

Read More

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

Tuesday, September 27 2022 | 15 h 29 min | News, Press Release

Bausch + Lomb announced the presentation of one podium and two poster presentations at the World Cornea Congress VIII meeting, which will take place...

Read More

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

Tuesday, May 24 2022 | 14 h 33 min | New Products, News, OptikTech

Bausch + Lomb announced that Health Canada has approved LUMIFY® (brimonidine tartrate ophthalmic solution 0025% w/v), the first and only over...

Read More

Bausch + Lomb Corporation Launches as a Publicly Traded Company

Friday, May 6 2022 | 15 h 49 min | Financial News, News, Press Release

Bausch + Lomb Corporation launched as a publicly traded company when it began trading under the "BLCO" symbol on the New York Stock Exchange and...

Read More

Bausch + Lomb Announces Statistically Significant Topline Results from Second Phase 3 Trial of NOV03

Wednesday, October 6 2021 | 11 h 29 min | News, Press Release

Bausch + Lomb and Novaliq announced statistically significant topline data from the second Phase 3 (MOJAVE) trial evaluating the investigational...

Read More